Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
REDWOOD CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming J.P. Morgan 43rd Annual Healthcare Conference in San Francisco, CA.
加州紅木城，2025年1月2日（全球新聞網絡）-- Seer, Inc.（納斯達克：SEER），一家領先的生命科學公司，正在商業化一種顛覆性的新的蛋白質組學平台，今天宣佈該公司將參加即將在加利福尼亞州舊金山舉行的第43屆J.P.摩根年度醫療保健會議。
Seer's management is scheduled to present and participate in a Q&A session on Wednesday, January 15th at 3:00 p.m. Pacific Time / 6:00 p.m. Eastern Time. A live webcast of the session will be available on the Investor section of Seer's website at investor.seer.bio. An archived replay will be available on the company's website following the conference.
Seer的管理層計劃於1月15日星期三太平洋時間下午3:00 / 東部時間下午6:00進行演示並參與問答環節。該會議的直播網絡研討會將會在Seer網站的投資者版塊提供，網址爲investor.seer.bio。會議結束後，公司網站上將提供存檔重播。
About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer's Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer's Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit .
關於Seer
Seer是一家生命科學公司，開發變革性產品，爲蛋白質組學開啓新的門戶。Seer的Proteograph產品套件是一個綜合解決方案，包括專利工程納米顆粒、消耗品、自動化儀器和軟體，可以在數小時內進行深入、公正的蛋白組分析。Seer設計了Proteograph工作流程，使其高效且易於使用，利用廣泛採用的實驗室儀器提供了一個去中心化的解決方案，可以被幾乎任何實驗室整合。Seer的Proteograph產品套件僅供研究使用，不用於診斷程序。有關更多信息，請訪問。
Media Contact:
Patrick Schmidt
pr@seer.bio
媒體聯繫人：
帕特里克·施密特
pr@seer.bio
Investor Contact:
Carrie Mendivil
investor@seer.bio
投資者聯繫人：
卡莉·門迪維爾
investor@seer.bio
譯文內容由第三人軟體翻譯。
